FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2018/10/015979 [Registered on: 10/10/2018] Trial Registered Prospectively
Last Modified On: 09/10/2018
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Placebo Controlled Trial 
Public Title of Study   A clinical trial to study the pain relief effect of two local anesthetic drugs ropivacaine and bupivacaine given to block the nerves located in abdominal wall after caesarean section.  
Scientific Title of Study   To Compare the efficacy of Ropivacaine versus Bupivacaine during Surgical transversus Abdominis plane block for post-operative analgesia after Caesarean Section 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Aniket Kakade 
Designation  Associate Professor  
Affiliation  Bharati Vidyapeeth [Deemed to be University] Medical College, Pune 
Address  Department of Obstetrics and Gynecology, Bharati Vidyapeeth [deemed to be University] Medical College, Dhankawadi, Pune

Pune
MAHARASHTRA
411043
India 
Phone  02045555555  
Fax    
Email  aniket1kakade@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Aniket Kakade 
Designation  Associate Professor  
Affiliation  Bharati Vidyapeeth [Deemed to be University] Medical College, Pune 
Address  Department of Obstetrics and Gynecology, Bharati Vidyapeeth [deemed to be University] Medical College, Dhankawadi, Pune


MAHARASHTRA
411043
India 
Phone  02045555555  
Fax    
Email  aniket1kakade@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Aniket Kakade 
Designation  Associate Professor  
Affiliation  Bharati Vidyapeeth [Deemed to be University] Medical College, Pune 
Address  Department of Obstetrics and Gynecology, Bharati Vidyapeeth [deemed to be University] Medical College, Dhankawadi, Pune


MAHARASHTRA
411043
India 
Phone  02045555555  
Fax    
Email  aniket1kakade@gmail.com  
 
Source of Monetary or Material Support  
Bharati Vidyapeeth [Deemed to be University] Medical College, Bharati Hospital and Research Center, Pune  
 
Primary Sponsor  
Name  Dr Aniket Kakade 
Address  Department of Obs & Gyn, 3rd Floor, Bharati Hospital, Bharati Vidyapeeth [Deemed to be University] Medical College, Dhankawadi, Pune 411043.  
Type of Sponsor  Other [Investigator Initiated Trial] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Aniket Kakade  Bharati Hospital & Research Center  Department of Obstetrics & Gynecology, 3rd Floor, Room of Associate Professor, Bharati Hospital, Dhankawadi
Pune
MAHARASHTRA 
9850988568

aniket1kakade@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Bharati VIdyapeeth [Deemed to be University] Medical College Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O82||Encounter for cesarean delivery without indication,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Bupivacaine  Bupivacaine will be used to administer Surgical Transversus Abdominis plane block. Dose is 0.25ml/kg of 0.25% Bupivacaine.  
Intervention  Ropivacaine  Ropivacaine will be used to administer the surgical transversus abdominis plane block.  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  all patients who require caesarean delivery 
 
ExclusionCriteria 
Details  Patient with ASA III or above
Any allergy to used drug
Local infection at the site of block
Patients requiring vertical abdominal incision and upper segment caesarean section
Patients requiring general anesthesia
Height of patient less than 150 cms and more than 180 cms (as these patients will require a different dosage of spinal anaesthesia)
Patients with thrombocytopenia.
 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Outcome Name: Post operative pain relief. To be assessed by Visual Analogue score [VAS]  Time Point: One hourly assessment for 8 hours 
 
Secondary Outcome  
Outcome  TimePoints 
Outcome Name: Side effects of the drugs   Time Points: Every hour assessment in post operative period for 24 hours.  
 
Target Sample Size   Total Sample Size="100"
Sample Size from India="100" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   01/11/2018 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   none yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Brief Summary   This is a randomized, double blind, parallel group trial to compare the efficacy of ropivacaine versus bupivacaine during surgical transversus abdominis plane [TAP]block for post-operative analgesia after caesarean section. Surgical TAP block is a established technique used for post operative analgesia. we plan to compare two drugs in 100 patients who require caesarean section. The post operative pain will be assessed by using the visual analogue scale [VAS] and the duration of analgesia in hours after giving the drug by TAP block will be assessed. Rescue analgesia will be administered to all those patients who complain of pain at VAS 3. The secondary outcome will be study of any side effects of the drugs.
 
Close